InnovAge Holding (InnovAge Holding) Additional Paid-In Capital : $336.6 Mil(As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is InnovAge Holding Additional Paid-In Capital?

InnovAge Holding's quarterly additional paid-in capital increased from Sep. 2023 ($333.3 Mil) to Dec. 2023 ($335.1 Mil) and increased from Dec. 2023 ($335.1 Mil) to Mar. 2024 ($336.6 Mil).

InnovAge Holding's annual additional paid-in capital increased from Jun. 2021 ($323.8 Mil) to Jun. 2022 ($327.5 Mil) and increased from Jun. 2022 ($327.5 Mil) to Jun. 2023 ($332.1 Mil).

InnovAge Holding Additional Paid-In Capital Historical Data

The historical data trend for InnovAge Holding's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnovAge Holding Additional Paid-In Capital Chart

InnovAge Holding Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Additional Paid-In Capital

35.80

36.34

323.76

327.50

332.11

InnovAge Holding Quarterly Data
	Jun19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial														330.96	332.11	333.32	335.06	336.60

InnovAge Holding Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

InnovAge Holding Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of InnovAge Holding's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

InnovAge Holding (InnovAge Holding) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » InnovAge Holding Corp (NAS:INNV) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

8950 East Lowry Boulevard, Denver, CO, USA, 80230

Website

https://www.innovage.com

InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.

Executives

Teresa Sparks	director	40 BURTON HILLS BOULEVARD SUITE 500, NASHVILLE TN 37215
Nicole Damato	officer: CHIEF LEGAL OFFICER	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Benjamin C Adams	officer: CHIEF FINANCIAL OFFICER	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Patricia Fontneau	director	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Christine Bent	officer: CHIEF OPERATIONS OFFICER	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Thomas Scully	director	320 PARK AVENUE, SUITE # 2500, NEW YORK NM 10022
Richard Feifer	officer: CHIEF MEDICAL OFFICER	C/O GENESIS HEALTHCARE, INC., 101 EAST STATE STREET, KENNETT SQUARE PA 19348
James G Carlson	director	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Patrick T Blair	officer: PRESIDENT	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Caroline Dechert	director	580 CALIFORNIA ST., SUITE 1700, SAN FRANCISCO CA 94104
Pavithra Mahesh	director	601 LEXINGTON AVE., 53RD FLOOR, NEW YORK NY 10022
Maureen Hewitt	director, officer: CEO, President and Director	8950 E. LOWRY BLVD., DENVER CO 80230
Maria Lozzano	officer: CORPORATE COO	8950 E. LOWRY BLVD., DENVER CO 80230
Robin Doerr	officer: CHIEF SALES AND MKTG. OFFICER	8950 E. LOWRY BLVD., DENVER CO 80230
Melissa Welch	officer: CHIEF MEDICAL OFFICER	8950 E. LOWRY BLVD., DENVER CO 80230